APA

Cojutti P. G., Candoni A., Lazzarotto D., Rabassi N., Fanin R., Hope W. & Pea F. (20191114). Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies. : British journal of clinical pharmacology.

Chicago

Cojutti Pier Giorgio, Candoni Anna, Lazzarotto Davide, Rabassi Nicholas, Fanin Renato, Hope William and Pea Federico. 20191114. Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies. : British journal of clinical pharmacology.

Harvard

Cojutti P. G., Candoni A., Lazzarotto D., Rabassi N., Fanin R., Hope W. and Pea F. (20191114). Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies. : British journal of clinical pharmacology.

MLA

Cojutti Pier Giorgio, Candoni Anna, Lazzarotto Davide, Rabassi Nicholas, Fanin Renato, Hope William and Pea Federico. Co-administration of proton pump inhibitors and/or of steroids may be a risk factor for low trough concentrations of posaconazole delayed-released tablets in adult patients with haematological malignancies. : British journal of clinical pharmacology. 20191114.